No evidence of association of two 5HT transporter gene polymorphisms and attention deficit hyperactivity disorder

Psychiatric Genetics

Volumn 13, Issue 2, 2003, Pages 107-110

  Langley, Kate ^a   Payton, Antony ^b   Hamshere, Marian L ^a   Pay, Helen M ^a   Lawson, Deborah C ^a   Turic, Darko ^a   Ollier, William ^b   Worthington, Jane ^b   Owen, Michael J ^a   O'Donovan, Michael C ^a   Thapar, Anita ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Association study; Attention deficit hyperactivity disorder; Genetics; Serotonergic system

Indexed keywords

SEROTONIN TRANSPORTER;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CASE CONTROL STUDY; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; GENE DELETION; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; STATISTICAL SIGNIFICANCE; TANDEM REPEAT;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CARRIER PROTEINS; CHILD; DNA; FEMALE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MINISATELLITE REPEATS; NERVE TISSUE PROTEINS; PARENTS; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

INSERTION SEQUENCES;

EID: 12444267903     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-200306000-00009     Document Type: Article

References (21)

1. Angold A, Prendergast M, Cox A, Harrington R, Simonoff E, Rutter M (1995). The Child and Adolescent Psychiatric Assessment. Psychol Med 25:739-753.
2. Barrickman L, Noyes R, Kuperman S, Schumacher E, Verda M (1991). Treatment of ADHD with fluvoxetine - a preliminary trail. J Am Acad Child Adolesc Psychiatry 30:762-767.
3. Campbell NB, Tamburrino MB, Evans CL, Franco KN (1995). Fluvoxetine for ADHD in a young child. J Am Acad Child Adolesc Psychiatry 34:1259-1260.
4. Clayton D (1999). A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 65:1170-1177.
5. Collier DA, Curran S, Asherson P (2000). Mission: not impossible? Candidate gene studies in child psychiatric disorders. Mol Psychiatry 5:457-460.
6. Faraone SV, Biederman J, Friedman D (2000). Validity of DSM-IV subtypes of attention-deficit/hyperactivity disorder: a family study perspective. J Am Acad Child Adolesc Psychiatry 39:300-307.
7. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG (1999). Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397-401.
8. Guy W (1976). ECDELL Assessment Manual for Psychopharmacology. Washington, DC: Department of Health, Education & Welfare. pp. 217-222.
9. Holmes J, Payton A, Barrett JH, Hever T, Fitzpatrick H, Trumper AL, et al. (2000). A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder. Mol Psychiatry 5:523-530.
10. Krawczak M, Konecki DS, Schmidtke J, Duck M, Engel W, Nutzenadel W, Trefz FK (1988). Allelic association of the cystic-fibrosis locus and 2 DNA markers, XV2C and KM19 in 55 German families. Hum Genet 80:78-80.
11. Kent L, Doerry U, Hardy E, Parmar R, Gingell K, Hawi Z, et al. (2002). Evidence that variation at the serotonin transporter gene influences susceptibility to Attention Deficit Hyperactivity Disorder (ADHD): analysis and pooled analysis. Molecular Psychiatry 7:908-912.
12. Lesch K-P, Bengal D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1530.
13. Manor I, Eisenberg J, Tyano S, Sever Y, Cohen H, Ebstein RP, Kotler M (2001). Family-based association study of the serotonin transporter promoter region polymorphism (5.HTTLPR) in attention deficit hyperactivity disorder. Am J Med Genet (Neuropsychiatr Genet) 105:91-95.
14. Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmer AJ, Goodwin GM, et al. (1996). Polymorphism in serotonin transporter gene associated with susceptibility to major depression. The Lancet 347:731-733.
15. Payton A, Holmes J, Barrett JH, Hever T, Fitzpatrick H, Trumpet AL, et al. (2001). Association between ADHD and candidate genes in the dopamine noradrenaline, and serotonin pathways: a family based study. Am J Med Genetics (Neuropsychiatr Genet) 105:464-470.
16. Rees M, Norton N, Jones I, McCandless F, Scourfield J, Holmans P, et al. (1997). Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT). Mol Psychiatry 2:398-402.
17. Seeger G, Schloss P, Schmidt MH (2001). Functional polymorphism within the promotor of the serotonin transporter gene is associated with severe hyperkinetic disorders. Mol Psychiatry 6:235-238.
18. Sham PC, Curtis D (1995). An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Annu Hum Genet 59:323-336.
19. Solanto MV (1998). Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94:127-152.
20. Thapar A, Holmes J, Poulton K, Harrington R (1999). Genetic basis of attention deficit and hyperactivity. Br J Psychiatry 174:105-111.
21. Thapar A (2002). Attention deficit hyperactivity disorder: new genetic findings, new directions. In: Piomin R, DeFries J, Craig IW, McGuffin P (editors): Behavioral Genetics in the Postgenomic era. American Psychological Association: Washington DC.